pharmaceutical intermediates topic page on Anadi Algo News

Monday, April 13, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
AnadiAlgoNews
सट्टा नहीं, सिस्टम
Topic Landing|80 matching stories

pharmaceutical intermediates News, Sentiment & Trading Insights

AI-analyzed coverage for the pharmaceutical intermediates theme, including latest market stories, signals and related articles.

What Traders Do Next

pharmaceutical intermediates is more useful with a process around it.

Use these pages to understand the story first. Execution usually comes later, after the idea is filtered, tested, and sized correctly.

Translate It into Rules

See how a market theme can turn into a structured workflow instead of impulse.

Check the Setup

Use a validation step before any trade decision starts feeling obvious.

Read the Main Algo Guide

Start broad if you want to understand the workflow before you optimize the setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Top Story|et_companiesabout 6 hours ago

India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership role

The Indian pharma sector is currently navigating a dynamic environment with a focus on innovation and reducing reliance on imports. This government push for biologics and biosimilars aligns with the global shift towards advanced therapies, making it a critical growth area.

Bullish+4890%
PharmaceuticalsHealthcare
+48

Impact Score

Sectors Impacted

PharmaceuticalsHealthcare
Maintain a bullish bias on select Indian pharma stocks, particularly those with strong R&D, manufacturing capabilities, and a focus on biologics/biosimilars. Look for consolidation or dips as buying opportunities.|Quick check: SUNPHARMA bearish bias (-3.5% 1d), CIPLA neutral (+0.4% 1d).
et_marketsabout 6 hours ago

Global Markets | Australian shares slide as US-Iran talks fail, risk appetite sours

Geopolitical tensions directly impact the Oil & Gas sector through crude price volatility and the Precious Metals sector as a safe-haven. This current event is a significant macro driver for both.

hold
Bearish-60.890%
5 factsONGC
Consider a long bias for upstream oil & gas (e.g., ONGC, RELIANCE) and gold stocks, while maintaining a short bias or caution on oil marketing companies (e.g., IOC, BPCL, HPCL) and broader market indices.|Quick check: ONGC bullish bias (overbought), SUNPHARMA bearish bias (-3.5% 1d).
MMB Larsenabout 7 hours ago

[MMB LT] Due to prediction of very good monsoon in India in 2026 which sectors will do well. These are FMCG coma Food coma Agro C...

The pharma sector is currently seeing mixed movements, with some stocks surging and others falling, as indicated by recent news. While the monsoon's direct impact on pharma is less, overall economic buoyancy from a good monsoon can indirectly support healthcare spending.

Bearish-1.515%
5 facts
For pharma, focus on companies with strong domestic portfolios and stable regulatory environments, considering the ongoing sector-specific news flow, rather than solely relying on monsoon predictions.|Quick check: SUNPHARMA bearish bias (-3.5% 1d), CIPLA neutral (+0.4% 1d).
MMB HDFC Bankabout 8 hours ago

[MMB HDF01] Best sectors for investment today are FMCG Food Agro Chemical and Pharma sectors. It is because of minimum crude oil imp...

The pharma sector often acts as a defensive play, less correlated with economic cycles and crude oil prices. Regulatory developments (USFDA) and product pipelines are key drivers for Indian pharma stocks.

Bearish-1.510%
5 facts
For pharma, look for companies with strong R&D, diversified product portfolios, and positive regulatory outcomes. Consider large-cap, fundamentally sound players for stability.|Quick check: SUNPHARMA bearish bias (-3.5% 1d), CIPLA neutral (+0.4% 1d).

Latest pharmaceutical intermediates Topic Coverage

et_marketsabout 12 hours ago+56.6

Stocks in news: LIC, Maruti Suzuki, Sun Pharma, TCS, HUL

hold5 factsLICMARUTISUNPHARMApharmaauto
Focus on stock-specific opportunities in large-cap names; consider long positions on positive news.|Quick check: LIC neutral, MARUTI bullish bias (+1.0% 1d).
et_companiesabout 18 hours ago+21.8

High Court relief to Sun Pharma, Ahd Co barred from using 'Esiraft'

sell5 factsSUNPHARMApharma
Positive sentiment for SUNPHARMA; potential for minor upside.|Quick check: SUNPHARMA bearish bias (-3.5% 1d), CIPLA neutral (+0.4% 1d).
et_economy1 day ago+58.8

Patent application filings in India rise 30.2% to 1.43 lakh in 2025-26: Goyal

5 factsmetalsbroad_market
Positive bias for companies with strong R&D and IP focus; look for sector-specific leaders.|Quick check: TATASTEEL bullish bias (+0.9% 1d), HINDALCO bullish bias (+0.5% 1d).
et_economy1 day ago+72.4

India-UK free trade pact may come into force from second week of May: Official

buy5 factsauto
Identify Indian companies with strong export ties to the UK for potential upside. Monitor domestic auto and spirits for competitive pressures.|Quick check: MARUTI bullish bias (+1.0% 1d), TATAMOTORS bullish bias (+3.1% 1d).
ValuePickr1 day ago+20.6

Control Print - Deserves attention?

sell5 factsCONTROLPRIndustrial ManufacturingCapital Goods
For industrial manufacturing stocks, look for companies with strong order books, capacity expansion plans, and technological partnerships, but always cross-reference with recent price action and market sentiment.|Quick check: CONTROLPR neutral, SUNPHARMA bearish bias (-3.5% 1d).
et_companies1 day ago-61.5

Pharma and healthcare companies to face continued margin pressure: HDFC Securities

5 factsPharmaceuticalsHealthcare
Maintain a cautious stance on pharma and healthcare stocks; look for shorting opportunities in companies that miss earnings expectations due to margin compression.|Quick check: SUNPHARMA bearish bias (-3.5% 1d), CIPLA neutral (+0.4% 1d).
et_companies2 days ago+43.8

Tiny hearts, big cardiac concern in India

5 factsHealthcarePharmaceuticals
Look for long-term investment opportunities in hospital chains with strong cardiac departments and pharmaceutical companies with a robust cardiovascular portfolio, anticipating sustained demand growth.|Quick check: TATASTEEL bullish bias (+0.9% 1d), HINDALCO bullish bias (+0.5% 1d).
ValuePickr2 days ago+39.2

Clean Science and Technology Limited (CSTL) - A clean and green future ahead

sell5 factsCLEANSpecialty ChemicalsPharmaceutical Intermediates
Look for opportunities in specialty chemical companies with strong balance sheets and expanding product lines, maintaining a long-term bullish bias.|Quick check: CLEAN bullish bias (+0.8% 1d), SUNPHARMA bearish bias (-3.5% 1d).
et_markets2 days ago+47.7

Aurobindo Pharma share buyback, Muthoot Fin dividend, 2 other corporate actions next week

buy5 factsAUROPHARMAMUTHOOTFINPharmaceuticalsFinancial Services
For pharma, look for companies with strong R&D and clear regulatory pathways; for financial services, focus on companies with robust balance sheets and consistent dividend payouts.|Quick check: AUROPHARMA bullish bias (overbought), MUTHOOTFIN bullish bias (+2.8% 1d).
ValuePickr2 days ago+34.1

Inox India, a story worth looking?

sell5 factsINOXINDIAIndustrial ManufacturingCryogenic Equipment
Look for entry points in fundamentally strong industrial stocks, focusing on companies with clear growth drivers and healthy balance sheets.|Quick check: INOXINDIA neutral (-3.3% 1d), SUNPHARMA bearish bias (-3.5% 1d).
ValuePickr2 days ago+47.2

Rubicon Research

5 factspharma
Consider a bullish stance on Rubicon Research, given its strong growth, profitability, and niche market position.|Quick check: SUNPHARMA bearish bias (-3.5% 1d), CIPLA neutral (+0.4% 1d).
ValuePickr2 days ago+13.1

Empire Industries

sell5 factsEMPINDSpharma
Approach Empire Industries with caution; consider it for long-term value if comfortable with limited information and diversified business risks.|Quick check: EMPINDS neutral, SUNPHARMA bearish bias (-3.5% 1d).
ValuePickr3 days ago+45.7

Sharda Cropchem - Can it get into indian market in a bigger way?

hold5 factsSHARDACROPChemicalsAgrochemicals
Monitor Sharda Cropchem for continued positive momentum, especially with upcoming Q4FY26 results. A break above recent highs could signal further upside, with a stop-loss below immediate support levels.|Quick check: SHARDACROP neutral, NIFTY neutral.
MMB Reliance3 days ago+11.1

[MMB RI] START BUY AND ADD MORE.... RELIANCE IND,,,MOREPEN LAB....PCBL.... ALEMBIC PHARMA....RTN IND.... GRANULES....ARE 10 TO 50...

hold5 factsMOREPENLABPCBLALEMBICPHPharmaceuticalsChemicals
Given the speculative nature of the source, traders should approach these recommendations with extreme skepticism. If considering these stocks, focus on fundamental analysis and technical indicators rather than MMB hype, maintaining strict stop-losses.|Quick check: MOREPENLAB neutral, PCBL bullish bias (+0.0% 1d).
livemint_markets3 days ago+26.2

Slowing growth and sticky inflation: Is it time to reduce US equity exposure?

5 factsInformation TechnologyPharmaceuticals
Consider defensive Indian pharma stocks with strong domestic focus or diversified global presence, while being cautious on those heavily reliant on US generics market.|Quick check: SUNPHARMA bearish bias (+0.1% 1d), CIPLA neutral (+0.7% 1d).
livemint_markets3 days ago-53

US sales may drag pharma companies’ Q4, even as India holds up

hold5 factsCIPLADRLZYDUSLIFEPharmaceuticals
Maintain a cautious stance on export-oriented Indian pharma stocks; look for companies with stronger domestic growth or diversified international presence as potential outperformers.|Quick check: CIPLA neutral (+0.7% 1d), DRL neutral.
et_markets3 days ago-60.8

Sun Pharma shares tumble 4% as firm closes in on $12-billion Organon acquisition. What’s spooking investors?

hold5 factsSUNPHARMAPharmaceuticals
Monitor other large-cap pharma stocks for contagion, but focus on company-specific news for Sun Pharma. Maintain a cautious stance.|Quick check: SUNPHARMA bearish bias (+0.1% 1d), CIPLA neutral (+0.7% 1d).
et_markets3 days ago+46

HDFC Bank, IT majors, and chemical stocks: Where Aditya Shah is hunting for value right now

hold5 factsHDFCBANKBankingInformation Technology
For banking, look for strong asset quality and deposit growth. For IT, consider long-term accumulation given current valuations, focusing on companies with strong deal pipelines.|Quick check: HDFCBANK neutral (-2.3% 1d), ICICIBANK neutral (-1.9% 1d).
et_companies3 days ago+48.6

Bottles, flasks grow scarce in India as gas crunch hits glassmakers

hold5 factspharma
Consider reducing exposure to companies heavily dependent on glass products or explore hedging strategies against rising input costs.|Quick check: SUNPHARMA bearish bias (+0.1% 1d), CIPLA neutral (+0.7% 1d).
ValuePickr3 days ago+48.6

Senores Pharma- Hidden in plain sight

5 factspharma
Consider a long-term investment in Senores Pharma, given its robust growth and strategic acquisitions that enhance its market position and export potential.|Quick check: SUNPHARMA bearish bias (+0.1% 1d), CIPLA neutral (+0.7% 1d).
et_companies4 days ago+56.1

Sun Pharma closes in on Organon buy, gets set for $12 billion binding bid

hold5 factsSUNPHARMApharma
Consider a positive bias for Sun Pharma, but also factor in the debt burden or equity dilution associated with such a large acquisition.|Quick check: SUNPHARMA bearish bias (+0.1% 1d), CIPLA neutral (+0.7% 1d).
et_companies4 days ago-55.9

Drugmaker Granules to tighten oversight after US FDA warning, executive says

hold5 factsGRANULESPharmaceuticals
Maintain a cautious stance on pharma stocks with significant US exposure, especially those with recent regulatory issues; look for companies with strong compliance records and diversified revenue streams.|Quick check: GRANULES bullish bias (-1.5% 1d), SUNPHARMA bearish bias (+0.1% 1d).
et_companies4 days ago+19.1

Centre in talks with Assam Petrochemicals, others to secure methanol supply for pharma amid West Asia disruptions

hold5 factsGNFCpharma
Bullish for the Indian pharma sector due to proactive government measures. Specifically positive for companies like GNFC involved in methanol production.|Quick check: GNFC neutral, SUNPHARMA bearish bias (+0.1% 1d).
et_markets4 days ago+64.3

Honasa Consumer among 7 stocks that hit 52-week high; rally up to 21% in a month

buy5 factsHONASAABBConsumer DurablesCapital Goods
Look for auto stocks with strong volume growth and positive demand mix, especially in the EV segment, but maintain strict stop-losses given the overall market volatility.|Quick check: HONASA bullish bias (overbought), ABB bullish bias (+0.4% 1d).
et_companies4 days ago+48.9

Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakers

sell5 factsPharmaceuticals
Look for Indian pharma stocks with established R&D and manufacturing for complex generics, with a bullish bias on those entering the weight-loss drug market.|Quick check: SUNPHARMA bearish bias (-0.5% 1d), CIPLA neutral (+1.2% 1d).
livemint_markets4 days ago-45.4

Sensex crashes 1,000 points a day after US-Iran ceasefire: Should you buy the dip as war clouds still linger?

buy5 factsINFYFinancialsInformation Technology
Maintain a cautious stance across sectors; for IT, consider short-term bearish bets given the underperformance expectation, while for financials, watch for further downside.|Quick check: INFY bullish bias (+0.6% 1d), NIFTY neutral.
et_markets4 days ago+44.7

Narendra Solanki sees limited IT growth, bets on rural and pharma plays

hold5 factsInformation TechnologyPharmaceuticals
Look for opportunities in pharmaceutical stocks with strong product pipelines and favorable regulatory outcomes, maintaining a long bias with strict stop-losses.|Quick check: TCS bullish bias (+0.7% 1d), SUNPHARMA bearish bias (-0.5% 1d).
livemint_markets4 days ago+35

Stock market today, 9 April: Gift Nifty dips; US-Iran war, India VIX to gold, silver rates — 8 stocks to buy or sell

buy5 factsAVANTIFEEDINDUSTOWERBANKINDIAAquacultureTelecommunications
For banking stocks, look for opportunities in fundamentally strong banks with improving asset quality and credit growth, but be mindful of deposit pricing pressures. Consider Bank of India as a potential buy based on expert recommendation.|Quick check: AVANTIFEED neutral, INDUSTOWER bullish bias (+3.6% 1d).
livemint_markets5 days ago+48.5

Lupin shares to be in focus on Thursday as USFDA approves Dapagliflozin and Metformin tablets

sell5 factsLUPINPharmaceuticals
Focus on pharma stocks with recent USFDA approvals; look for sustained upward momentum post-announcement with strict stop-losses.|Quick check: LUPIN neutral (-0.2% 1d), SUNPHARMA bearish bias (-0.5% 1d).
ValuePickr5 days ago+54.7

Yash Pakka - (Previously Yash Paper) - Rising from ash

buy5 factsYASHPAKKAbanking
Positive bias for packaging companies, particularly those focused on sustainable and innovative solutions.|Quick check: YASHPAKKA neutral, HDFCBANK bullish bias (+5.9% 1d).
ValuePickr5 days ago+0.7

Alembic Pharma (Oral Solids ==> Injectables, Onco, Derma, Opthalmic)

sell5 factsALEMBICLTDAPLLTDpharma
Neutral for short-term; for long-term, analyze current financials against this historical backdrop.|Quick check: ALEMBICLTD neutral, APLLTD bearish bias (-3.6% 1d).
ValuePickr5 days ago+4.5

Acutaas Chemicals (formerly Ami Organics) - Pharma Intermediates & Specialty Chemicals

hold5 factsAMIORGSpecialty ChemicalsPharmaceuticals
For specialty chemical and pharma intermediate players, monitor order book growth, capacity expansion, and regulatory approvals for new products, with a long-term bullish bias.|Quick check: AMIORG neutral, SUNPHARMA bearish bias (+1.4% 1d).
ValuePickr5 days ago+42

Innova Captab Limited: CDMO play

hold5 factsINNOVACAPPharmaceuticalsContract Development and Manufacturing Organization (CDMO)
Focus on companies with strong CDMO capabilities and diversified revenue streams, as they are well-positioned to capitalize on global supply chain shifts.|Quick check: INNOVACAP neutral, SUNPHARMA bearish bias (+1.4% 1d).
et_economy5 days ago+40

US envoy to India meets Trump, discusses 'strong future of India-US ties'

5 factsInformation TechnologyPharmaceuticals
Look for Indian IT and Pharma stocks with strong US revenue exposure; consider accumulating on dips, with a focus on companies that have a good track record with USFDA compliance for pharma.|Quick check: SUNPHARMA neutral (+1.4% 1d), CIPLA bearish bias (oversold).
ValuePickr5 days ago+23.6

Why Good Companies Often Deliver Poor Returns (A Missing Layer in Stock Analysis)

sell5 factsTORNTPHARMpharma
Focus on identifying fundamentally strong pharma companies that are trading at reasonable valuations, rather than just growth. Consider a value-oriented approach.|Quick check: TORNTPHARM bearish bias (oversold), SUNPHARMA neutral (+1.4% 1d).
et_markets6 days ago-5

Soleno withdraws EU rare disease drug application ahead of Neurocrine takeover

5 factsPharmaceuticals
Maintain a neutral stance on Indian pharma stocks based on this news; focus on company-specific pipeline developments and USFDA approvals for actionable trades.|Quick check: SUNPHARMA neutral (+1.4% 1d), CIPLA bearish bias (oversold).
ValuePickr6 days ago-2.2

Chemcon Speciality Chemicals - Red herring or True Value

hold5 factsCHEMCONpharmachemicals
No immediate trade setup based on this stale news. For current investors, it offers background on the company's initial market perception.|Quick check: CHEMCON neutral, SUNPHARMA neutral (+1.4% 1d).
et_markets6 days ago+65

Market Trading Guide: Buy Ramco Systems, Natco Pharma and 2 more stocks on Wednesday for gains up to 14%

buy5 factsRAMCOSYSNATCOPHARMInformation TechnologyPharmaceuticals
Look for entry points in recommended IT and Pharma stocks on minor dips, targeting the stated upside potential with defined risk management.|Quick check: RAMCOSYS neutral, NATCOPHARM bullish bias (overbought).
et_companies6 days ago+41.5

Biocon rolls out two biosimilars in US market

sell5 factsBIOCONPharmaceuticals
Maintain a bullish bias on Biocon, looking for sustained upward momentum; monitor sales figures and future pipeline developments for continued strength.|Quick check: BIOCON bearish bias (-4.2% 1d), SUNPHARMA neutral (+1.4% 1d).
et_economy6 days ago+45.4

India–New Zealand FTA likely to be signed on April 24, may bring $20 billion investment boost over 15 years

hold5 factsCONCORSCItradelogistics
Research specific Indian industries that could benefit most from tariff-free access to New Zealand (e.g., textiles, pharmaceuticals, IT services).|Quick check: CONCOR neutral (+0.9% 1d), SCI neutral (+0.0% 1d).
et_economy6 days ago-65

Morgan Stanley cuts India’s FY27 growth outlook to 6.2% amid Gulf conflict

sell5 factsPharmaceuticalsTextiles
Monitor pharma and textile stocks for signs of increased input costs impacting quarterly results; consider shorting or reducing positions in companies with high import dependencies.|Quick check: SUNPHARMA neutral (+1.4% 1d), CIPLA bearish bias (oversold).
livemint_markets6 days ago-44

Stocks to buy: Sagar Doshi suggests Laurus Labs, Data Patterns, Syrma SGS shares to buy

buy5 factsLAURUSLABSDATAPATTNSSYRMAPharmaceuticalsElectronics Manufacturing Services
Maintain a cautious stance; consider reducing exposure to high-beta stocks and focus on capital preservation. Look for potential shorting opportunities in weaker sectors or consider long positions in defensive stocks if the geopolitical situation worsens.|Quick check: LAURUSLABS bullish bias (+1.1% 1d), DATAPATTNS neutral (+1.5% 1d).
et_markets6 days ago+45.8

War or no war: BofA cites nearly 50 stocks that could perform well irrespective of geopolitical outcome

5 factsPharmaceuticalsJewellery
Look for entry points in fundamentally strong companies within the mentioned sectors, focusing on those with stable earnings and low sensitivity to global shocks.|Quick check: HDFCBANK neutral (+2.5% 1d), ICICIBANK bearish bias (+1.0% 1d).
livemint_markets6 days ago+70

Stock market today: Gift Nifty down; US-Iran war, India VIX to oil, gold, silver rates — eight stocks to buy or sell

buy5 factsGRANULESCCLDLFPharmaceuticalsFMCG
Given the geopolitical risks, traders should monitor crude oil price movements closely; a spike could negatively impact oil-importing sectors and consumer discretionary stocks.|Quick check: GRANULES bullish bias (+6.0% 1d), CCL bullish bias (+2.7% 1d).
ValuePickr7 days ago+52.5

Aeroflex Industries Ltd - The future of flexible engineering?

hold5 factsAEROFLEXSATINDLindustrial_manufacturingengineering
Look for entry points in Aeroflex Industries, considering its growth trajectory and expansion plans. Monitor capex execution.|Quick check: AEROFLEX neutral, SATINDL neutral.
et_markets7 days ago+74.9

Market Trading Guide: Buy Adani Green, RBL Bank and 3 more stocks on Tuesday for gains up to 8%

buy5 factsADANIGREENRBLBANKGRANULESBankingPharmaceuticals
Maintain a bullish bias on select banking stocks, focusing on those showing strong technical breakouts and volume, with strict stop-losses.|Quick check: ADANIGREEN bullish bias (+8.2% 1d), RBLBANK bullish bias (+5.3% 1d).
et_companies7 days ago-1.6

Aristo Pharma buys office space for Rs 111 crore in Mumbai’s Andheri West

5 factsPharmaceuticalsReal Estate
Look for opportunities in commercial real estate developers with significant Mumbai presence, as demand from end-users like pharma companies remains strong.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
livemint_markets7 days ago-60.5

Indian rupee weakness: Temporary shock or structural decline—or both?

hold5 factsIOCOil & GasIT Services
Bearish bias for oil marketing companies (OMCs) due to higher crude import costs; bullish bias for export-oriented sectors like IT and Pharma due to favorable currency conversion.|Quick check: IOC bearish bias (oversold), TATASTEEL bullish bias (+1.2% 1d).
et_companies7 days ago+27

Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj Chinthalapelly

5 factsBiotechnologyPharmaceuticals
Consider long positions in fundamentally strong Indian biotech and pharma companies with a focus on R&D and innovation, with a stop-loss below recent support levels.|Quick check: HDFCBANK neutral (+2.5% 1d), ICICIBANK bearish bias (+1.0% 1d).
et_markets7 days ago+52.5

Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challenges

hold5 factsJUBILANTPHARPIRAMALPHSUNPHARMAPharmaceuticalsAutomobiles
Look for entry points in auto stocks on minor dips, and for pharma, focus on companies with strong domestic strategies or specific product advantages.|Quick check: JUBILANTPHAR neutral, PIRAMALPH neutral.
MMB Axis Bank7 days ago+5.2

[MMB UTI10] Join Telegram SENSEXNOW sharp moves don’t mean clear direction, let the market show intent, updates here nif.ty.25.8.786...

hold5 factsSENSEXbroad_marketbanking
Maintain a cautious stance; consider defensive strategies or short-term trades with strict stop-losses, favoring a bearish bias until market intent is clearly established.|Quick check: SENSEX neutral, NIFTY neutral.
et_markets7 days ago+63.2

US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip Bandyopadhyay

buy5 factsVEDLNATIONALUMTATASTEELMetals & MiningPharmaceuticals
Maintain a cautious stance on pharma stocks with high branded drug exposure; consider defensive plays or companies with strong domestic focus and diversified product pipelines.|Quick check: VEDL bullish bias (+1.4% 1d), NATIONALUM bullish bias (+0.1% 1d).
et_markets7 days ago+46.3

Aurobindo Pharma approves Rs 800 crore share buyback. Check record date, other key details

sell5 factsAUROPHARMAPharmaceuticals
Maintain a positive outlook on Aurobindo Pharma, watching for increased institutional interest and potential short covering post-buyback announcement.|Quick check: AUROPHARMA bullish bias (-0.5% 1d), SUNPHARMA bearish bias (oversold).
et_markets7 days ago-71.5

Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocks

sell5 factsSUNPHARMAPharmaceuticals
Focus on Indian pharma companies with strong generic pipelines or those less exposed to patented drugs in the US, while being cautious on specialty pharma players.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
livemint_markets7 days ago+46.3

Aurobindo Pharma declares buyback of shares at ₹1475. Size, record date, other details

sell5 factsAUROPHARMAPharmaceuticals
Look for entry points in Aurobindo Pharma, considering the buyback price as a potential support level, with a stop-loss below recent lows.|Quick check: AUROPHARMA bullish bias (-0.5% 1d), SUNPHARMA bearish bias (oversold).
ValuePickr8 days ago+12

Honeywell Automation - Is this a secular growth story?

sell5 factsHONAUTpharma
Neutral to slightly bullish bias. Look for positive macroeconomic indicators related to industrial production and gas-based economy initiatives. Monitor news on new project wins in pharma/specialty chemicals.|Quick check: HONAUT bearish bias (oversold), SUNPHARMA bearish bias (oversold).
et_companies8 days ago+33.5

Grey Market: India is ageing faster than its care systems can keep up. A new wave of startups is trying to bridge that gap

5 factsHealthcarePharmaceuticals
Look for companies with strong R&D in age-related diseases, diagnostics, or those expanding into eldercare services, with a long-term bullish bias.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_companies9 days ago+49.4

Comm secy asks pharma sector to cut dependence on imported raw materials

hold5 factsGRANULESSOLARApharma
Look for opportunities in API-focused pharma companies, as this policy push could drive their growth and profitability.|Quick check: GRANULES neutral (-2.5% 1d), SOLARA neutral.
et_companies9 days ago+34.4

Work on reducing import dependence for raw materials: Commerce Secretary Rajesh Agrawal to pharma industry

sell5 factsSUNPHARMALUPINAUROPHARMAPharmaceuticalsChemicals
Look for pharma companies with strong R&D, backward integration into APIs, and a growing export footprint; consider accumulating on dips with a medium to long-term horizon.|Quick check: SUNPHARMA bearish bias (oversold), LUPIN bearish bias (-0.4% 1d).
et_companies9 days ago+39

Lalitpur Pharma Park gets export push as UPSIDA, JNPA sign pact

sell5 factsSUNPHARMAPharmaceuticalsLogistics
Look for opportunities in large-cap and mid-cap pharma stocks with strong export footprints, anticipating a positive impact on their top and bottom lines due to reduced logistics costs and increased market reach.|Quick check: SUNPHARMA bearish bias (oversold), HDFCBANK neutral (+0.9% 1d).
et_economy9 days ago+54

EU-India FTA may boost India's competitiveness in some sectors, says EY report on European economic outlook

5 factsmanufacturingtextiles
Look for long opportunities in export-oriented Indian companies, particularly those with established European market presence or strong competitive advantages.|Quick check: NIFTY neutral, SENSEX neutral.
et_companies9 days ago+38.1

India’s pharma exports stay resilient amid global headwinds, near $29 billion mark

sell5 factsSUNPHARMALUPINAUROPHARMAPharmaceuticalsHealthcare
Look for long positions in established Indian pharmaceutical companies with diversified product portfolios and strong export revenues, maintaining a stop-loss below recent support levels.|Quick check: SUNPHARMA bearish bias (oversold), LUPIN bearish bias (-0.4% 1d).
et_companies9 days ago+32.2

Israel, Iran war: Torrent Gas raises CNG price by Rs 2.50/kg; locals flag rising cost burden

sell5 factsTORNTPHARMMGLIGLOil & GasCity Gas Distribution
Maintain a cautious to bearish bias on CGD stocks; monitor crude oil and natural gas price trends closely for further direction.|Quick check: TORNTPHARM bearish bias (oversold), MGL neutral (oversold).
et_companies10 days ago+26

Govt orders safety review of popular weight-loss drugs amid rising demand

sell5 factsPharmaceuticals
Maintain a cautious bias on pharma stocks directly involved in weight-loss drugs until the implications of the safety review are clearer; consider long positions in companies known for strong regulatory compliance and R&D.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_companies10 days ago+37.3

AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence

sell5 factsPharmaceuticalsInformation Technology
Maintain a bullish bias on pharma, focusing on companies investing in R&D and AI, with a stop-loss below recent support levels.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_companies10 days ago-11.5

India largely shielded from US tariffs on patented drugs due to generic export strength: GTRI

5 factsPharmaceuticals
Focus on large-cap generic drug manufacturers with diversified export portfolios, as they are less exposed to these specific tariffs.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
livemint_markets10 days ago-71.5

Sun Pharma share price in focus on Monday after Trump's tariff announcement

sell5 factsSUNPHARMAPharmaceuticals
Maintain a bearish bias on Indian pharma stocks with high US exposure; look for short opportunities on any relief rallies, with strict stop-losses.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_companies10 days ago+11

India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation

5 factsPharmaceuticalsHealthcare
Look for Indian pharma companies with strong pipelines or existing products in the obesity/diabetes segment, with a bullish bias for long-term growth.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
livemint_markets10 days ago+15

Rajesh Palviya of Axis Sec suggests Voltamp Transformers, Shilpa Medicare, Persistent Systems shares to buy on April 6

hold5 factsVOLTAMPSHILPAMEDPERSISTENTCapital GoodsPharmaceuticals
Maintain a cautious but opportunistic approach; focus on fundamentally strong stocks with expert recommendations, while keeping an eye on crude oil trends and RBI policy decisions.|Quick check: VOLTAMP neutral, SHILPAMED neutral.
et_markets10 days ago-75.2

Pharma calls in sick after Trump’s 100% tariff threat

5 factsPharmaceuticals
Maintain a bearish bias on Indian pharma stocks, especially those with high US revenue concentration, until clarity emerges on potential tariffs.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_markets10 days ago-71.4

Rupee at 100 will be a harsh check on India’s ambitions

sell5 factsHDFCBANKBankingOil & Gas
Maintain a bearish bias on banking stocks; monitor NIMs and asset quality closely, as rising interest rates and economic slowdown could increase NPAs.|Quick check: HDFCBANK neutral (+0.9% 1d), ICICIBANK bearish bias (+0.3% 1d).
et_economy11 days ago+27.1

Key petrochemical products get 3 month import duty relief

sell5 factsRELIANCEPIDILITINDpharmaenergy
Identify companies with significant petrochemical input costs in the affected sectors. This could lead to margin expansion or increased demand.|Quick check: RELIANCE bearish bias (-1.4% 1d), PIDILITIND bearish bias (-2.8% 1d).
et_economy11 days ago+45.4

India is looking at preferential access to US market, says Piyush Goyal

5 factsbroad_market
Look for companies in sectors like textiles, pharmaceuticals, and IT services that have significant export exposure to the US. Positive news on BTA could be a catalyst.|Quick check: NIFTY neutral, BANKNIFTY neutral.
et_companies11 days ago+11

CCTV in medical stores may become mandatory; DCC proposes rule change

5 factsPharmaceuticalsRetail
Consider a neutral to slightly negative bias for unorganized pharmacy retail, while organized players might see long-term benefits from a more regulated market.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_companies11 days ago-64

Indian pharma sector faces supply risk amid West Asia conflict despite duty waiver

sell5 factsPharmaceuticals
Maintain a bearish bias on pharma stocks, focusing on companies with diversified supply chains or strong backward integration as potential outperformers.|Quick check: SUNPHARMA bearish bias (oversold), CIPLA bearish bias (oversold).
et_economy11 days ago+34

Several measures announced to cushion exporters from Gulf conflict impact: DGFT

sell5 factsTITANPIDILITINDICICIBANKGems & JewelleryFood Processing
Monitor banking and insurance stocks for positive sentiment, especially those with significant exposure to export finance and trade credit insurance, with a bullish bias on improved asset quality and business prospects.|Quick check: TITAN neutral (+0.5% 1d), PIDILITIND bearish bias (-2.8% 1d).
pharmaceutical intermediates News, Sentiment & Trading Insights | Anadi Algo News